MedTrace Logo

Association of Two Desensitizing Protocols to Control Dentinal Hypersensitivity in Non-carious Lesions

NCT04642001 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2020-11-27

No results posted yet for this study

Summary

This randomized, double-blind clinical trial evaluated the effect of photobimodulation associated with 8% strontium acetate in the treatment of dentin hypersensitivity in non-carious lesions and analyzed the risk factors with the patient's quality of life.

Conditions

  • Dental Hypersensitivity

Interventions

OTHER

Photon Laser III-DMC (without radiation emission) + My First- Colgate

Positioning of the FBM (Photon Laser III / DMC) without emitting radiation, the equipment's sound was mimicked with the Beep application (Foncannon Inc, Google, © 2018), followed by the use of fluoride-free toothpaste (My First- Colgate) and brushing three times a day.

OTHER

Photon Laser III-DMC (without radiation emission) + Sensodyne® Rapid Relief / GSK

Positioning of FBM (Photon Laser III / DMC) without emitting radiation, the equipment's sound was mimicked with the Beep application (Foncannon Inc, Google, © 2018), followed by the application of toothpaste containing strontium acetate (Sensodyne® Rapid Relief / GSK) and brushing three times a day.

RADIATION

Photon Laser III-DMC (with irradiation emission) + My First- Colgate

Emission of FBM therapy (Photon Laser III / DMC), followed by the use of fluoride-free toothpaste (My First- Colgate) and brushing three times a day.

COMBINATION_PRODUCT

Photon Laser III-DMC (with irradiation emission) +Sensodyne® Rapid Relief / GSK

Emission of FBM therapy (Photon Laser III / DMC), followed by the application of toothpaste containing strontium acetate (Sensodyne® Rapid Relief / GSK) and brushing three times a day.

Sponsors & Collaborators

  • Universidade Federal do Para

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
FACTORIAL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-08-07
Primary Completion
2020-09-15
Completion
2020-11-05

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04642001 on ClinicalTrials.gov